抗逆转录病毒方案对美国接受过治疗的人类免疫缺陷病毒1型感染成人脑脊液病毒逃逸的影响:一项前瞻性多队列研究
该前瞻性多队列研究纳入2005至2016年间1063例基线血浆病毒载量≤400拷贝/mL的成人,评估抗逆转录病毒方案与脑脊液病毒逃逸的关系。中位随访4.4年期间77例(7.2%)发生脑脊液逃逸,蛋白酶抑制剂联合核苷类逆转录酶抑制剂(PI+NRTI)方案是脑脊液逃逸的独立预测因素(OR 3.1,95%CI 1.8-5.0),含阿扎那韦方案预测性更强。
要点
- PI+NRTI方案是HIV感染成人脑脊液病毒逃逸的独立预测因素(OR 3.1,95%CI 1.8-5.0)。
- 含阿扎那韦的方案对脑脊液病毒逃逸的预测性强于不含阿扎那韦的PI+NRTI方案。
- 合并M184V/I突变者中调整后中枢神经系统穿透有效性评分低(<5)见于79%的脑脊液逃逸病例。
核心结论
- PI+NRTI方案是HIV感染成人脑脊液病毒逃逸的独立预测因素。
- 中枢神经系统抗逆转录病毒生物利用度降低可能使携带M184V/I突变的患者易发生脑脊液病毒逃逸。
研究设计与样本
- 前瞻性多队列研究,纳入2005至2016年间基线血浆病毒载量≤400拷贝/mL的1063例参与者。
- 采用混合效应模型估计抗逆转录病毒方案(PI+NRTI对比其他方案)与脑脊液病毒逃逸的比值比(OR)。
主要发现
- 基线平均年龄46岁,血浆病毒载量中位数50拷贝/mL,CD4计数中位数424个/μL。
- 中位随访4.4年期间,77例参与者(7.2%)发生脑脊液病毒逃逸。
- 校正分析中PI+NRTI使用是脑脊液病毒逃逸的独立预测因素(OR 3.1;95%CI 1.8-5.0),在限制于血浆病毒载量≤50拷贝/mL的模型中亦如此(P<.001)。
- 含阿扎那韦(ATV)的方案对脑脊液病毒逃逸的预测性强于不含ATV的PI+NRTI方案。
- 血浆和脑脊液M184V/I合并胸苷类似物突变在脑脊液逃逸者中比无逃逸者更常见(23% vs 2.3%)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebrospinal fluid (CSF) viral escape occurs in 4%-20% of human immunodeficiency virus (HIV)-infected adults, yet the impact of antiretroviral therapy (ART) on CSF escape is unclear. METHODS: A prospective study of 1063 participants with baseline plasma viral load (VL) ≤400 copies/mL between 2005 and 2016. The odds ratio (OR) for ART regimens (protease inhibitor with nucleoside reverse transcriptase inhibitor [PI + NRTI] vs other ART) and CSF escape was estimated using mixed-effects models. RESULTS: Baseline mean age was 46 years, median plasma VL, and CD4 count were 50 copies/mL, and 424 cells/μL, respectively. During median follow-up of 4.4 years, CSF escape occurred in 77 participants (7.2%). PI + NRTI use was an independent predictor of CSF escape (OR, 3.1; 95% confidence interval, 1.8-5.0) in adjusted analyses and models restricted to plasma VL ≤50 copies/mL (P < .001). Regimens that contained atazanavir (ATV) were a stronger predictor of CSF viral escape than non-ATV PI + NRTI regimens. Plasma and CSF M184V/I combined with thymidine-analog mutations were more frequent in CSF escape vs no escape (23% vs 2.3%). Genotypic susceptibility score-adjusted central nervous system (CNS) penetration-effectiveness (CPE) values were calculated for CSF escape with M184V/I mutations (n = 34). Adjusted CPE values were low (<5) for CSF in 27 (79%), indicating suboptimal CNS drug availability. CONCLUSIONS: PI + NRTI regimens are independent predictors of CSF escape in HIV-infected adults. Reduced CNS ART bioavailability may predispose to CSF escape in patients with M184V/I mutations.
引用
- Mukerji SS, Misra V, Lorenz DR, et al. Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States. Clin Infect Dis. 2018. PMID: 29617912. doi:10.1093/cid/ciy267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。